Guide for patients & caregivers

Intestinal Metaplasia in the Stomach: What Does a Biopsy Result Mean?

Gastric intestinal metaplasia on a biopsy explained: the H. pylori link, cancer risk in plain terms, extent and type, when surveillance is offered.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What does intestinal metaplasia in the stomach mean?

Gastric intestinal metaplasia (often shortened to GIM or IM) means that some of the cells lining the stomach have changed to look more like the cells that line the intestines. It is usually found on biopsies taken during an upper endoscopy (gastroscopy). It is not cancer, but it is linked to a higher risk of stomach cancer, so doctors consider whether follow-up is needed.

Cleveland Clinic describes metaplasia as a response to long-term irritation of the stomach lining, and says it usually causes no symptoms of its own. It is often found when an endoscopy is done for another reason, such as indigestion or reflux.

This guide focuses on the biopsy term itself. Separate guides cover H. pylori testing and mild gastritis on endoscopy, and the same cell change in the food pipe is covered in our Barrett's oesophagus guide.

Symptoms that need urgent care

Intestinal metaplasia rarely causes symptoms itself, but new or worsening symptoms should not wait for a planned endoscopy. The NHS advises calling the emergency number or going to A&E if:

  • you are vomiting bright red blood or your vomit looks like ground coffee;
  • your poo has blood in it, or is black, sticky and very smelly;
  • you have severe tummy pain, or your tummy is painful to touch.
  • Get a prompt medical appointment for problems swallowing, weight loss without trying, a lump in your tummy, repeated vomiting, or feeling full after very little food. Guts UK advises people on surveillance to seek urgent advice for new symptoms rather than waiting for the next endoscopy.

Is gastric intestinal metaplasia cancer?

No. Intestinal metaplasia is a change in cell type, not cancer. The British Society of Gastroenterology (BSG) describes a series of stages that can, in some people, lead towards stomach cancer: chronic gastritis, gastric atrophy (thinning of the lining), intestinal metaplasia and then dysplasia (more abnormal, precancerous cells).

Most people do not move through all these stages. Cleveland Clinic says intestinal metaplasia may progress to cancer over time in a small percentage of people, and that most cases will not. Guts UK notes that the risk depends on how much of the stomach is affected.

Numbers in studies vary between countries and populations, so it is more useful to ask your own team how they view your risk than to rely on a single figure from the internet.

Why does H. pylori matter?

Helicobacter pylori is a common stomach infection that can cause long-term inflammation. Cleveland Clinic and Guts UK both link it to intestinal metaplasia. The other main cause named in these sources is autoimmune gastritis, which is associated with pernicious anaemia.

The American Gastroenterological Association (AGA) 2020 guideline strongly recommends that people with GIM are tested for H. pylori and treated if it is present. The BSG suggests that clearing H. pylori may be of some benefit in reducing cancer risk in people who already have H. pylori-related intestinal metaplasia.

Guts UK suggests asking whether you have H. pylori and whether you will be tested to check that treatment worked. Treatment choice is made by your clinician; do not stop or change any prescribed medicine without talking to the prescriber.

What do extensive, focal, complete and incomplete mean?

Reports may describe how much of the stomach is affected and what type of change is seen. These details help doctors judge risk:

  • Focal or limited: the change is in a small area, often just the lower part of the stomach (the antrum).
  • Extensive: the change is found in more than one area, for example both the antrum and the body of the stomach. Cleveland Clinic says extensive IM is more likely to progress.
  • Complete: the cells look more like small-intestine cells.
  • Incomplete: the cells look more like large-intestine (colon) cells. Cleveland Clinic says this type is more likely to progress to dysplasia.
  • Dysplasia: if a report mentions low-grade or high-grade dysplasia, that is a different, more significant finding and needs specific advice from your team.

Will I need surveillance endoscopy?

Surveillance means repeat endoscopies to look for further change early. Guidance differs between countries, which is why two people with the same term on a report may get different plans.

The BSG (2019) recommends offering endoscopic surveillance every 3 years to people with extensive gastric atrophy or intestinal metaplasia, defined as affecting both the antrum and the body. It does not recommend surveillance when the change is limited to the antrum, unless there are added risk factors such as a strong family history of stomach cancer or persistent H. pylori infection.

The AGA (2020) suggests against routine surveillance for everyone with GIM, but says people at higher risk may reasonably choose it after shared decision-making. It lists incomplete or extensive GIM, a family history of stomach cancer, and coming from a region with high stomach cancer rates among the factors linked to higher risk. Where surveillance is chosen, it says repeat endoscopy every 3 to 5 years could be considered.

Guts UK adds that surveillance is not right for everyone, for example because of other health conditions, and that sedation or a through-the-nose endoscopy may be options if the test is difficult for you.

Can intestinal metaplasia go away, and what can I do?

Cleveland Clinic says it is not yet clear whether intestinal metaplasia reverses once the cause is removed, and that studies have not shown this conclusively. Treatment focuses on removing irritants, such as treating H. pylori, so the lining has the best chance to recover.

Guts UK suggests not smoking, keeping a healthy weight and keeping alcohol within national guidance. Cleveland Clinic also mentions eating less salt and more fruit and vegetables. These steps support general stomach health; they are not a guarantee.

Questions to ask your clinician

Take your endoscopy and biopsy reports with you. These questions can help:

  • Is my intestinal metaplasia focal or extensive, and where in the stomach is it?
  • Is it complete or incomplete, and was any dysplasia seen?
  • Did the biopsies show H. pylori, and how will we confirm it has gone after treatment?
  • Does my family history or background change my risk?
  • Which guideline are you following, and do I need another endoscopy? If so, when?
  • Who should I contact if I don't hear about my next appointment?
  • What changes might help reduce my risk?

How comparing similar cases on SameCase can help you prepare

On SameCase, patients and verified doctors share de-identified cases. Seeing how others with a gastric intestinal metaplasia result described their report, H. pylori treatment and follow-up plan may help you think of questions you had not considered.

Other people's cases cannot tell you your own risk or whether you need surveillance. Bring the questions you collect to your own care team.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning